Tisdag 26 Augusti | 17:00:53 Europe / Stockholm
Svenska | English
Investor Relations
Public Relations

FluoGuide A/S

Prenumeration

Filter arrow-icon
Språk arrow-icon
Rensa
Se endast PM som skrivits på följande språk
Se endast PM som skrivits på följande språk
2025-08-10 10:06:00
FluoGuide Q&A sessions highlight partnerships accelerating FG001 commercialization
Copenhagen, Denmark, 10 August 2025 – FluoGuide A/S is releasing a summary of its live-recorded interview at Redeye (English) on 8 August 2025 and its live Q&A session hosted by FluoGuide (Danish) on 8 August 2025. Both focused on the company’s partner-driven strategy to accelerate the commercialization of FG001 and expand its market potential
2025-07-31 08:54:00
Invitation: FluoGuide presentations on strategic collaborations and FG001 commercialization
FluoGuide is advancing its position in head and neck cancer treatment. On 21 July 2025, the company announced a strategic collaboration with Olympus, a global med‑tech leader. The collaboration aims to jointly develop FG001 for tumor imaging and surgical margin assessment in head and neck cancer, focusing on the clinical phase and gathering evidence on Olympus’s imaging platforms
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden